Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Janux Therapeutics Inc (JANX)

Healthcare Biotechnology
15.20 $
-2.6% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Janux Therapeutics Inc (JANX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 64.2% of the shares are freely tradable; institutional investors hold 102.7%.

Ownership Structure

Institutional ownership
102.7%
Insiders
6.6%
Float
64.2%
Short % of float
16.0%
Shares Outstanding
61Mio.

Largest Shareholders

Institutions

Institutions JANX
Name Stake (%) Shares Change (%) Date
RA Capital Management, LLC 18.35 11,189,693 +0.0 03/31/2026
BlackRock Inc 8.91 5,433,233 +33.2 03/31/2026
HHG PLC 6.88 4,196,409 -21.6 03/31/2026
Prosight Management, LP 5.82 3,550,000 +48.4 03/31/2026
Vanguard Group Inc 4.77 2,906,386 +20.2 12/31/2025
FMR Inc 4.16 2,535,724 -27.8 03/31/2026
State Street Corp 4.04 2,464,017 -36.1 03/31/2026
Vanguard Capital Management, LLC 2.97 1,811,365 +0.0 03/31/2026
TCG Crossover Management, LLC 2.93 1,789,617 +0.0 03/31/2026
Alyeska Investment Group, L.P. 2.63 1,601,089 +23.1 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
31. Jul 2026 Campbell David Alan President and CEO Other 123,840 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?